SARS-CoV-2 from COVID-19 Patients in the Republic of Moldova: Whole-Genome Sequencing Results.
COVID-19
Moldova
SARS-CoV-2
molecular epidemiology
viral strains
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
21 10 2022
21 10 2022
Historique:
received:
16
08
2022
revised:
12
10
2022
accepted:
14
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Since the onset of the COVID-19 pandemic, no viral genome sequences of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have been documented from the Republic of Moldova, a developing country geographically located in Eastern Europe between Romania and Ukraine. Here, we report the analysis of 96 SARS-CoV-2 sequences from Delta and Omicron variants of the SARS-CoV-2 cases in the Republic of Moldova obtained between August and November 2021 and between January and May 2022. Comparison to global viral sequences showed that among the Delta variant of the SARS-CoV-2, AY.122 (n = 25), followed by AY.4.2.3 (n = 6), AY.4 (n = 5), AY.43 (n = 3), AY.98.1 (n = 3), B.1.617.2 (n = 1), AY.125 (n = 1), AY.54 (n = 1), AY.9 (n = 1), AY.126 (n = 1), and AY.33 (n = 1) were the most frequently found lineages. Furthermore, 10 lineages of the Omicron variant, namely, BA.2 (n = 14), followed by BA.2.9 (n = 10), BA.1 (n = 5), BA.1.1 (n = 5), BA.1.18 (n = 4), BA.1.15.1 (n = 3), BA.1.17.2 (n = 2), BA.1.17 (n = 2), BA.1.15 (n = 1), and BA.2.1 (n = 1) were detected. In addition, we also identified the impact of the military crisis between Russia and Ukraine, when the COVID-19 epidemiological rules collapsed, on the distribution of Delta and Omicron variants in the Republic of Moldova. Additional studies are warranted to characterize further the impact of the war between Russia and Ukraine on the genomic epidemiology of the SARS-CoV-2 in the Republic of Moldova and Eastern Europe.
Identifiants
pubmed: 36298865
pii: v14102310
doi: 10.3390/v14102310
pmc: PMC9610950
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIA NIH HHS
ID : R01AG064003
Pays : United States
Organisme : NIA NIH HHS
ID : K02AG068595
Pays : United States
Références
Trends Neurosci. 2022 May;45(5):358-368
pubmed: 35279295
Nat Biotechnol. 2020 Mar;38(3):276-278
pubmed: 32055031
Brief Bioinform. 2004 Jun;5(2):150-63
pubmed: 15260895
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595
pubmed: 32571934
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
World Psychiatry. 2022 Feb;21(1):124-132
pubmed: 34612005
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
Sci Transl Med. 2022 Sep 28;14(664):eabq3059
pubmed: 35857629
Cell Res. 2021 Dec;31(12):1230-1243
pubmed: 34663909
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
Expert Rev Vaccines. 2021 Oct;20(10):1201-1209
pubmed: 34488546
Curr Res Struct Biol. 2021;3:290-300
pubmed: 34806033
Mol Biol Evol. 2021 Jun 25;38(7):3022-3027
pubmed: 33892491
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807